Find Academic Supervisors

• Horticultural Crop Breeding
• Plant Genetics
• Genome Analysis
• +2 more

Ki Hwan Song is a Professor in the Department of Bioindustry and Bioresource Engineering at Sejong University. He has held academic and research positions since 2015, following a career in plant breeding at Dongbu Farm Hannong (2007-2015), Monsanto China (2000-2007), and Dong-Yang-Moolsan Co. (1996-1999). His research focuses on horticultural crop breeding, genome analysis, and molecular marker development for stress tolerance and disease resistance. Ph.D. in Plant Breeding, Seoul National University (1997) M.S. and B.S. in Plant Science, Seoul National University (1992, 1990) Song's research spans genetic resource development for disease resistance (cucurbit crops), genome-wide association studies (GWAS), and molecular breeding techniques. His work includes high-throughput sequencing for gene discovery, SNP marker development, and stress tolerance mechanisms in cucumbers and pumpkins. Recent publications highlight advancements in yellow endocarp genetics , cucurbitacin profiling , and chilling tolerance in Cucurbitaceae species. Key keywords across his 29 research outputs include plant genetics, genomics, molecular biology, and stress tolerance. He leads the Plant Breeding Laboratory (Da434) at Sejong University, with contributions to patents in cucumber genetics and stress-tolerant cultivars. His teaching includes graduate courses in seed production and vegetable science.

• Regeneration and Stem Cells
• Disease Mechanisms and Therapeutics
• Retinal Biology
• +3 more

Timothy A Blenkinsop is an Associate Professor at the Icahn School of Medicine at Mount Sinai , affiliated with the Department of Ophthalmology and Cell, Developmental & Regenerative Biology . His research focuses on retinal regeneration, particularly the biology of the retinal pigment epithelium (RPE) , with an emphasis on developing in vitro disease models, epigenetic profiling, and transplantation strategies for RPE-related pathologies. Education: PhD in Developmental Biology, New York University BS in Cell Biology, University of Wisconsin at Whitewater His work bridges regenerative medicine and translational ophthalmology , with key contributions to understanding RPE dysfunction in diseases like Age-Related Macular Degeneration (AMD) and Proliferative Vitreoretinopathy (PVR) . Recent publications highlight advancements in stem cell-derived RPE therapy, contractility inhibition, and viral ocular infection models. Dr. Blenkinsop's laboratory develops 3D eye organoids , epigenetic profiling tools , and NRF2 signaling modulators to address retinal degeneration. His research has implications for therapeutic development, including preclinical models and biofunctional polymers to prevent retinal scarring. Office Location: Annenberg Building, Floor 22, Room A22-08, 1468 Madison Ave, New York, NY 10029 .

• Genome Regulation
• Epigenomics
• Chromatin Architecture
• +5 more

Suhn K. Rhie, PhD, is an Assistant Professor in the Department of Biochemistry and Molecular Medicine at the Keck School of Medicine of the University of Southern California, where she leads the Rhie Lab within the Norris Comprehensive Cancer Center. Her research program centers on understanding gene regulation in normal and diseased cells through integrative genomic approaches, with a focus on epigenetic mechanisms in cancer biology. Dr. Rhie's work spans four interconnected research pillars: Genome Wide Association Studies (GWAS), Regulatory Elements, Chromatin Interactions, and Transcription Factors. She investigates epigenomic dysregulation in prostate and bladder cancers, with dedicated emphasis on health disparities affecting African American populations. Her lab develops computational tools like TENET for regulatory network tracing and Methyl-Micro-C for multi-omic chromatin profiling, bridging wet-lab experimentation with advanced bioinformatics. Analysis of her 2023-2025 publications reveals consistent innovation in epigenomic technologies, particularly in characterizing DNA methylation signatures across racial groups in prostate cancer, dissecting 3D chromatin architecture in tumorigenesis, and developing methods for simultaneous assessment of multiple epigenetic layers. Her work frequently addresses therapy resistance mechanisms and racial disparities through multi-ethnic genomic studies. Dr. Rhie mentors trainees in her laboratory and secures competitive research funding to advance her agenda on cancer epigenetics and health equity, with publications demonstrating sustained productivity in high-impact venues despite the absence of explicitly listed grants in available materials. The Rhie Lab operates at the intersection of computational biology and experimental cancer research within USC's Norris Comprehensive Cancer Center. Her team leverages cutting-edge genomic technologies to map regulatory landscapes in cancer, with particular focus on translating epigenetic discoveries into clinical applications for personalized cancer care and addressing systemic disparities in cancer outcomes through rigorous molecular analysis.

• Preventive Medicine
• Immunology
• Sports Nutrition
• +9 more

Katsuhiko Suzuki is a Professor at the Faculty of Sport Sciences, Waseda University and former Adjunct Professor at Institute of Biomedical Innovation, Queensland University of Technology . His research bridges preventive medicine, immunology, and sports nutrition , focusing on exercise-induced inflammation, muscle recovery, and nutritional interventions . PhD in Medicine (Hirosaki University) M.S. in Human Sciences (Waseda University) Research Highlights : • Enduromics and Resistomics for personalized training • Sulforaphane , flavonoids , and polyphenols in oxidative stress modulation • Neutrophil dynamics in post-exercise recovery and renal injury prevention • 85% dark chocolate for PMS-related performance optimization in female athletes Scientific Leadership : Editorial roles in Frontiers in Physiology and Nutrition President of International Society of Exercise and Immunology (2015-2017) Awards : • Incentive Award, Japanese Society of Physical Fitness and Sports Medicine (2023) • Young Investigators Award, International Society of Exercise and Immunology (2001) Recent Publication Trends : • 2025: 11 articles on nutraceuticals (probiotics, capsaicin, dark chocolate) for muscle recovery and inflammatory modulation • 2024: 7 papers on epigenetic aging , remote training for Alzheimer's , and Caveolin gene interactions • 2023: 4 studies on caffeine dosing , flavonoids in sarcopenia , and keto diet mechanisms

David MonkView profile

Professor

• Developmental Epigenetics
• Genomic Imprinting
• DNA Methylation
• +7 more

David Monk is Professor of Developmental Epigenetics at the University of East Anglia, School of Biological Sciences, where he also serves as the Cells & Tissues Theme Leader. His research focuses on epigenetic mechanisms in human development and disease, with emphasis on genomic imprinting, DNA methylation, and placental biology. Research Interests: His work investigates how epigenetic regulation influences fetal growth, imprinting disorders, and cancer. He employs high-throughput genomic technologies, single-cell epigenomics, and genome editing to dissect the interplay between genetic variation and epigenetic marks, especially in early development and placental function. Recent Research Trends: His most recent publications (2023–2025) highlight a strong focus on placenta-specific imprinting, non-canonical methylation patterns, transcriptomic alterations in complicated pregnancies, and epigenetic defects in early embryonic development. The integration of single-cell multi-omics and low-input profiling is a recurring methodological theme. Scientific Awards: Ramon y Cajal Career Development Fellowship Grants and Advising: He leads multiple active research projects funded by the BBSRC, MRC, and NHS-affiliated trusts. While specific students are not listed, his publications indicate active mentorship of researchers in epigenetics and developmental biology. Labs and Teams: He leads a research team at UEA focused on developmental epigenetics, and collaborates with international institutions, including IDIBELL (Barcelona), and clinical partners such as Norfolk & Norwich University Hospitals NHS Foundation Trust.

Jesús Israel Pagán MuñozView profile

Associate Professor

• Plant Virology
• Epidemiology of Infectious Diseases
• Evolutionary Biology
• +3 more

Jesús Israel Pagán Muñoz is an Associate Professor at the Universidad Politécnica de Madrid (UPM) , leading the research group 'Determinants of Plant Virus Seed Transmission and Speciation' at the Centro de Biotecnología y Genómica de Plantas (UPM-INIA/CSIC) . His work focuses on understanding plant virus emergence, speciation, and seed transmission dynamics, with applications in sustainable agriculture and biotechnology. His research addresses ecological and genetic factors influencing virus speciation in Iberian ecosystems, seed transmission mechanisms in Arabidopsis thaliana , and collaborations on animal/human RNA virus evolution. Key projects include studying biodiversity impacts on virus prevalence and biotech strategies to combat seed-transmitted pathogens. Funding includes grants from the Spanish Ministry of Economy and Competitiveness (BIO2016-79165-R) and Marie Curie Actions (PCIG11-GA-2012-322100). Recent articles highlight plant-virus interactions under stress, phage therapy for antibiotic-resistant bacteria, and seed transmission quantification. Advising : Supervising PhD student Lucía García Ordoñez and collaborating with postdocs and technicians. Labs/Teams : CBGP's Plant-Virus Interaction Lab and interdisciplinary groups studying viral evolution and ecology. Future Work : Biotech partnerships to develop seed-transmission-resistant crops and ecological modeling of pathogen emergence.

Ruth CliffordView profile

Adjunct Associate Professor

• Malignant Haematology
• Genomic Drivers of Blood Cancer
• Chemotherapy Resistance
• +6 more

Ruth Clifford is an Adjunct Associate Professor at the School of Medicine , University of Limerick, and a Consultant Haematologist at University Hospital Limerick (UHL) since 2016. Her clinical focus spans lymphoid malignancies , particularly chronic lymphocytic leukaemia (CLL), while her research integrates genomics and artificial intelligence to address genetic drivers of blood cancers and chemotherapy resistance . Education: MD from NUI Galway (2002) PhD in Haematology Genomics, University of Oxford (CRUK Fellowship) Ruth's work explores genomic mechanisms in blood cancers, including the discovery of SAMHD1 mutations as biomarkers for CLL resistance. She pioneers AI-driven diagnostic pathways and leads national initiatives like the Enhanced Blood Cancer Outcomes Registry (EBCOR) . Her recent publications focus on: Lymphoma follow-up strategies Bleeding prevention in thrombocytopenic cancer patients Genomic risk profiling in myeloma Genotype-phenotype interactions in Down syndrome leukaemia Scientific awards include the Cancer Research UK Fellowship . Ruth serves as translational co-chair of Cancer Trials Ireland's Haematology and Lymphoma DSSG and contributes to the National Cancer Control Programme's molecular advisory group. Ruth collaborates extensively across Blood Cancer Network Ireland , ULCan's Basic Sciences Pillar, and the Limerick Digital Cancer Research Centre to advance cancer research infrastructure in Ireland.

Sergio RutellaView profile

Professor

• Haematological Cancers
• Immunotherapy
• Acute Myeloid Leukemia (AML)
• +12 more

Professor Sergio Rutella is a licensed haematologist and Director of the John van Geest Cancer Research Centre at Nottingham Trent University . With over 230 peer-reviewed publications and an H-index of 67, his work bridges translational immunology and cancer biology to advance antibody-based therapies and haematopoietic stem cell transplantation . PhD in Experimental Haematology (Catholic University Medical School, Rome) Specialisation in Haematology ( summa cum laude , Rome) Full Registration with Italian Medical Council GMC Specialist Registration in Haematology (UK) Rutella's research focuses on AML immunotherapy , dissecting how IFN-gamma signaling and TP53 mutations drive immune evasion. His team uses single-cell RNA sequencing , spatial transcriptomics , and bioinformatics to identify predictive biomarkers and tailor precision immunotherapy clinical trials . His 2020–2025 publications reveal trends in immune landscape analysis , checkpoint modulators , and AML microenvironment . Notable findings include the role of IFN-stimulated genes in chemotherapy resistance and the 3-gene signature predicting AML outcomes. Fellow, Royal Society of Biology (2022) Vice Chancellor's Outstanding Researcher Award (2019) Scientific Advisory Board, DFG Collaborative Research Centre Editorial Roles: Journal of Clinical Medicine , Frontiers in Immunology As Principal Investigator for >£12M in grants (Wugen, MacroGenics, Sheffield Charity, Kura Oncology), Rutella collaborates with institutions in Germany, Italy, USA, and Qatar. His lab's work on flotetuzumab and memory-like NK cells has been featured in Blood , Science Translational Medicine , and Blood Cancer Discovery .

Ninan AbrahamView profile

Professor

• Immunology
• Cell and Developmental Biology
• Lymphocyte Development
• +3 more

Ninan Abraham is a Professor at the Department of Zoology, University of British Columbia, and affiliated with the Life Sciences Institute. His research focuses on immunology and cell biology, particularly the role of interleukin-7 (IL-7) in lymphocyte development, immune responses to viral infections, and cancer immunology. He leads the Abraham Lab, which investigates mechanisms of immune suppression in tumors, T cell differentiation, and cytokine signaling pathways. Research Trends: His recent work examines how tumor-secreted CCL5 drives immunosuppression in lung cancer (2022), the role of CD4⁺ Trm cells in anti-tumor responses, and peripheral blood biomarkers for immune checkpoint therapy efficacy. Earlier studies (2011-2016) explored IL-7Rα signaling pathways, STAT5's role in lymphomagenesis, and glucocorticoid regulation in lymphoid organs. Key Collaborations: Affiliated with the Canadian Society for Immunology and involved in cross-disciplinary projects at the intersection of zoology, microbiology, and immunology research.

Joseph P. StainsView profile

Professor

• Bone Biology
• Connexin43 Signaling
• Osteoblast Differentiation
• +3 more

Joseph P. Stains, PhD, is a Professor in the Department of Orthopaedics with secondary appointment in Physiology at University of Maryland School of Medicine. He leads the Division of Musculoskeletal Science and maintains affiliations with multiple research centers including the Center for Research on Aging and Center for Stem Cell Biology. Education: B.S. in Molecular & Cell Biology (1994), PhD in Biochemistry (2000) from Penn State University Appointments: Postdoc at Washington University (2001-2004), then continuously at University of Maryland since 2004 Dr. Stains' research focuses on bone cell signaling through connexin43-containing gap junctions , examining how intercellular communication coordinates osteoblast differentiation and osteocyte mechanotransduction . His work mechanistically links cytoskeletal dynamics to sclerostin regulation via NOX2-ROS-TRPV4-CaMKII pathways. His lab has produced over 65 peer-reviewed publications with recent emphasis on microtubule rheostats and Ca²⁺-dependent bone remodeling . Funding includes NIH R01 grants (2013-2025), DoD , and Maryland Stem Cell Research Fund awards. Scientific Leadership: ASBMR Fellow (2020), NIH Study Section Member Academic Service: Graduate Council, School of Medicine Council, Course Director for GPLS 645

Muhammad RaiView profile

Assistant Professor

• Osteoarthritis
• Molecular Biology
• Genetic Mouse Models
• +5 more

Muhammad Rai is an Assistant Professor at Khalifa University , affiliated with the College of Medicine and Health Sciences in the Department of Biological Sciences . Previously, he served as a research faculty member at Washington University School of Medicine , USA. Dr. Rai earned his PhD in Biochemistry from the Free University of Berlin , Germany, and holds a Master of Science in Cellular and Molecular Biology from Washington University School of Medicine. PhD - Freie Universität Berlin, Germany MSc - Washington University School of Medicine, St. Louis, USA MS - University of Veterinary & Animal Sciences, Lahore, Pakistan Dr. Rai’s research focuses on: Understanding early molecular mechanisms in post-traumatic osteoarthritis Developing nanoparticle-RNAi therapies targeting periostin Investigating genetic heterogeneity in cartilage repair Proteomic and transcriptomic profiling of joint tissues Linking obesity to osteoarthritis via gene expression Elucidating heritability of regenerative capacity His publications span biochemistry, genetics, orthopedics, and nanomedicine , with a focus on post-traumatic osteoarthritis , RNA interference , and mouse models . Key trends include identifying preclinical biomarkers and inflammatory pathway modulation. Awards: K99/R00 Pathway to Independence Award, T32 Postdoctoral Fellowship, multiple ORS and OARSI recognitions Students: Supervising 3 PhD candidates and 2 SRP students Labs: Leads research on musculoskeletal repair at the Center for Biotechnology Research

• Leukemia
• Biostatistics
• Computational Biology
• +6 more

Tim Triche, Jr., Ph.D., is an Associate Professor at the Van Andel Institute in the Department of Epigenetics . He earned his A.B. in chemistry from Cornell University , followed by an M.S. in biostatistics and a Ph.D. in statistical genetics from the University of Southern California . Before joining Van Andel in 2017, he was a postdoctoral fellow at USC's Norris Comprehensive Cancer Center focusing on cellular senescence in blood disorders. As a key member of The Cancer Genome Atlas Research Network since 2011 with over a dozen high-impact publications in Nature , Cell , and NEJM , Dr. Triche specializes in epigenetics , biostatistics , and computational biology . His lab develops innovative approaches for pediatric AML research, integrating next-generation sequencing with clinical trial design to improve patient outcomes. His work emphasizes statistical learning for patient stratification, molecular profiling of hematological cancers, and interpretable machine learning in biomedical contexts. He leads the Bioinformatics and Biostatistics Core as faculty advisor and maintains active collaborations across institutions. 2025 Nature Cancer study on developmental heterogeneity in cancer susceptibility 2024 NAR methods paper on BISCUIT multi-omics tools 2023 PLOS One validation of MAX regulation in pituitary adenomas 2022 Nature Metabolism obesity subtyping analysis Scientific contributions include: Chan Zuckerberg Initiative grant (2022) for biomedical computing NCI SPORE grant (2021) as co-recipient Key role in Pediatric AML molecular mapping (2017)

Michiel VermeulenView profile

Professor

• Systems Biology
• Proteomics
• Cellular Differentiation
• +8 more

Michiel Vermeulen is a Full Professor in Proteomics and Chromatin Biology at the Department of Molecular Biology, Radboud University Nijmegen, Netherlands. He previously held positions as Associate and Assistant Professor at University Medical Center Utrecht (2009-2014) and completed postdoctoral work at Max Planck Institute for Biochemistry (2005-2009) and a PhD at Radboud University (2000-2005). His research focuses on integrative omics approaches to study gene expression regulation in development and disease, particularly through chromatin interactions and post-translational modifications. Education: PhD in Molecular Biology, Radboud University Nijmegen (2000-2005) Postdoc in Proteomics & Signal Transduction, Max Planck Institute Munich (2005-2009) His work pioneers quantitative mass spectrometry technologies to analyze chromatin-associated proteins, including m6A RNA modifications and ubiquitin signaling. He has published 97 papers and received multiple accolades, including ERC Starting and Consolidator Grants, a VIDI award, and membership in the Oncode Institute. His lab leads collaborative studies on chromatin readers, DNA damage response, and transcriptional regulation. Scientific Awards: ERC Consolidator Grant (2017) ERC Starting Grant (2012) Vernieuwingsimpuls VIDI award (2009) Max Planck Institute Junior Research Award (2008) Van Nieuwenhoven Award for Best Master Student (2000) Oncode Institute Founding Member (2017) Vermeulen's lab collaborates internationally and mentors 6 PhD students, 6 postdocs, and technicians, emphasizing high-impact interdisciplinary research in chromatin biology and systems-level gene regulation.

• Cancer Genomics
• Bioinformatics
• Oncology
• +5 more

Prof. Giovanni Tonon is a Full Professor at Vita-Salute San Raffaele University and holds key leadership roles including Director of the Center for Omics Sciences and Head of the Functional Genomics of Cancer Unit at the San Raffaele Scientific Institute in Milan, Italy. His academic journey includes a Medical Degree from the University of Padua (110/110 cum laude) and a PhD in Clinical Methodology from the University of Milan. He has held prestigious positions at institutions like Harvard Medical School and the NIH in the US. His research focuses on genomic and bioinformatics approaches to identify cancer-related genes/pathways, with particular emphasis on multiple myeloma and CAR T-cell therapies. He has pioneered studies on DNA damage responses in cancer and developed novel diagnostic/therapeutic technologies. His work integrates molecular oncology, epigenetics, and precision medicine. Prof. Tonon has secured major awards including the Leukemia & Lymphoma Society Special Fellow Award (2006-2009) and holds 7 patents related to cancer diagnostics and therapies. He actively contributes to teaching, leading courses in Molecular Oncology, Gene Expression Analysis, and Scientific Writing at San Raffaele University. His research group collaborates internationally, driving initiatives like the DigiONE federated learning system for precision oncology. Education: PhD in Clinical Methodology, University of Milan (2002) Medical Degree, University of Padua (1992) Music Professor Certification in Piano, Conservatory of Venice (1989) Key Roles: Director, Center for Omics Sciences (2016-present) Unit Head, Functional Genomics of Cancer (2008-present) Professor of Molecular Oncology (2008-2016) His lab focuses on translating genomic discoveries into clinical applications, with recent work advancing CAR T-cell therapies for colorectal cancer and developing federated learning systems for oncology research. He maintains active participation in doctoral programs in Neurocognitive Sciences and serves on institutional research committees.

Veronica RadiceView profile

Research Fellow

• Coral Biology
• Marine Ecology
• Oceanography
• +3 more

Dr. Veronica Radice is a Research Fellow at the University of Queensland and a member of the Australian Research Council Centre of Excellence for Coral Reef Studies. Her work focuses on coral physiology in relation to environmental conditions, particularly in mesophotic ecosystems, using biogeochemical techniques, genetics, and field experiments to study impacts of ocean warming and thermal stress on coral recovery from bleaching. Education: Bachelor’s degree in Biology from Johns Hopkins University, followed by research assistant and lab manager roles at Temple University. Research: Investigates coral trophic ecology, nutrient cycling, and gene expression under climate stress, with fieldwork in the Indo-Pacific and Maldives. Awards: XL Catlin Seaview Survey Ocean Scholar. Expertise: Mesophotic coral ecosystems, coral bleaching resilience, biogeochemistry, and oceanographic influences on reef productivity. Resources: Contributed to datasets and platforms like Mesophotic.org for coral reef research.